Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
Saved in:
| Title: | Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. |
|---|---|
| Authors: | Pan C; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Ng K; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA., Voutsinas J; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA., Barber B; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Rizvi ZH; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.; Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA., Marchiano E; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Ferrandino RM; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Futran N; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Laramore GE; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Liao JJ; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Parvathaneni U; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Panjwani N; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Martins RG; Division of Hematology, Oncology and Palliative Care, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA., Rodriguez CP; Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Wu QV; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. qwu@fredhutch.org. |
| Source: | BMC cancer [BMC Cancer] 2024 Nov 15; Vol. 24 (1), pp. 1406. Date of Electronic Publication: 2024 Nov 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39543541 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pan+C%22">Pan C</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Ng+K%22">Ng K</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.<br /><searchLink fieldCode="AU" term="%22Voutsinas+J%22">Voutsinas J</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.<br /><searchLink fieldCode="AU" term="%22Barber+B%22">Barber B</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Rizvi+ZH%22">Rizvi ZH</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.; Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Marchiano+E%22">Marchiano E</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Ferrandino+RM%22">Ferrandino RM</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Futran+N%22">Futran N</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Laramore+GE%22">Laramore GE</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Liao+JJ%22">Liao JJ</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Parvathaneni+U%22">Parvathaneni U</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Panjwani+N%22">Panjwani N</searchLink>; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Martins+RG%22">Martins RG</searchLink>; Division of Hematology, Oncology and Palliative Care, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+CP%22">Rodriguez CP</searchLink>; Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+QV%22">Wu QV</searchLink>; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. qwu@fredhutch.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2024 Nov 15; Vol. 24 (1), pp. 1406. <i>Date of Electronic Publication: </i>2024 Nov 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39543541 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-024-13051-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1406 Titles: – TitleFull: Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pan C – PersonEntity: Name: NameFull: Ng K – PersonEntity: Name: NameFull: Voutsinas J – PersonEntity: Name: NameFull: Barber B – PersonEntity: Name: NameFull: Rizvi ZH – PersonEntity: Name: NameFull: Marchiano E – PersonEntity: Name: NameFull: Ferrandino RM – PersonEntity: Name: NameFull: Futran N – PersonEntity: Name: NameFull: Laramore GE – PersonEntity: Name: NameFull: Liao JJ – PersonEntity: Name: NameFull: Parvathaneni U – PersonEntity: Name: NameFull: Panjwani N – PersonEntity: Name: NameFull: Martins RG – PersonEntity: Name: NameFull: Rodriguez CP – PersonEntity: Name: NameFull: Wu QV IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2024 Nov 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |